Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
2.
Rev Clin Esp ; 189(5): 218-20, 1991 Oct.
Article in Spanish | MEDLINE | ID: mdl-1801069

ABSTRACT

One hundred and sixty-four AIDS patients were studied; in 70 of them (42.7%) an agent capable of producing diarrhea was identified either by bacteriology, histopathology, or both procedures. It was observed that homosexuals and bisexuals present diarrhea sooner and with a higher frequency than heterosexuals. Cryptosporidium (35.7%) was the most frequently isolated agent. The most useful study was the coproparasitoscopic series. In 27 patients (38.6%) 2 or more agents (pathogens or opportunist) were isolated. An statistical correlation was demonstrated between the presence of diarrhea and the existence of agents able to produce it. The convenience of using special methods, because of their efficacy or cost, to evidence other pathogenic or opportunistic agents is also discussed.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Diarrhea/etiology , Hospitalization , Opportunistic Infections/etiology , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/microbiology , Acquired Immunodeficiency Syndrome/parasitology , Adult , Diarrhea/epidemiology , Diarrhea/microbiology , Diarrhea/parasitology , Feces/microbiology , Feces/parasitology , Female , Hospitals, General , Humans , Male , Mexico/epidemiology , Opportunistic Infections/epidemiology , Opportunistic Infections/microbiology , Opportunistic Infections/parasitology , Sex Factors , Urban Population/statistics & numerical data
3.
Ann N Y Acad Sci ; 284: 272-7, 1977 Mar 04.
Article in English | MEDLINE | ID: mdl-360901

ABSTRACT

1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) at a dosage of 300 mg/day, or disguised placebo was administered to patients in a closed population during an epidemic outbreak of influenza in Mexico City. Treatment consisted of capsules given three times daily for 5 days beginning with first signs of disease. The study was conducted in a double-blind fashion. Clinical manifestations of the disease, as well as in titer of recoverable virus and in specific serum antibody titer were significantly reduced in the ribavirin-treated group. None of the individuals in the study had any sign of toxic effects attributable to the drug. In the study, 21 patients received the drug and 24 received placebo.


Subject(s)
Influenza, Human/drug therapy , Ribavirin/therapeutic use , Ribonucleosides/therapeutic use , Adolescent , Child , Clinical Trials as Topic , Double-Blind Method , Female , Humans , Influenza, Human/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...